Home › Ulcerative Colitis › Virginia › Roanoke
Ulcerative Colitis clinical trials in Roanoke, VA
4 studies for Ulcerative Colitis are looking for participants at sites in and around Roanoke (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
RecruitingPhase 3
- Gastroenterology Consultants of Southwest Virginia, Roanoke
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
RecruitingPhase 2
- Carilion Clinic, Roanoke
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
RecruitingPhase 4
- Gastroenterology Consultants of Southwest Virginia., Roanoke
A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
RecruitingPhase 3
- Carilion Children's Tanglewood Center, Roanoke
About Ulcerative Colitis
Ulcerative Colitis (UC) can cause long-lasting swelling and ulcers in the large intestine. It is a type of inflammatory bowel disease. Find out more.
More about Ulcerative Colitis on MedlinePlus
Ulcerative Colitis trials in other cities
- Orlando, FL21 studies
- New York City, NY21 studies
- Miami, FL20 studies
- Houston, TX14 studies
- San Diego, CA13 studies
- Chicago, IL13 studies
- Tacoma, WA13 studies
- St. Louis, MO13 studies
- Tyler, TX13 studies
- San Antonio, TX13 studies
- Colorado Springs, CO12 studies
- Boston, MA12 studies
Other studies in Roanoke
- Colorectal Cancer10 studies
- Non-Small Cell Lung Cancer8 studies
- Heart Failure8 studies
- Breast Cancer7 studies
- Metastatic Cancer6 studies
- Prostate Cancer6 studies
- Stomach Cancer4 studies
- Small Cell Lung Cancer4 studies
- Diabetic Foot4 studies
- Crohn's Disease4 studies
- Melanoma4 studies
- Ovarian Cancer4 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.